1. Home
  2. VRDN vs CDLR Comparison

VRDN vs CDLR Comparison

Compare VRDN & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • CDLR
  • Stock Information
  • Founded
  • VRDN 2006
  • CDLR 2008
  • Country
  • VRDN United States
  • CDLR Denmark
  • Employees
  • VRDN N/A
  • CDLR N/A
  • Industry
  • VRDN Medical Specialities
  • CDLR
  • Sector
  • VRDN Health Care
  • CDLR
  • Exchange
  • VRDN Nasdaq
  • CDLR Nasdaq
  • Market Cap
  • VRDN 1.6B
  • CDLR 1.6B
  • IPO Year
  • VRDN N/A
  • CDLR N/A
  • Fundamental
  • Price
  • VRDN $23.63
  • CDLR $18.53
  • Analyst Decision
  • VRDN Strong Buy
  • CDLR
  • Analyst Count
  • VRDN 10
  • CDLR 0
  • Target Price
  • VRDN $36.78
  • CDLR N/A
  • AVG Volume (30 Days)
  • VRDN 1.5M
  • CDLR 92.3K
  • Earning Date
  • VRDN 11-13-2025
  • CDLR 11-25-2025
  • Dividend Yield
  • VRDN N/A
  • CDLR N/A
  • EPS Growth
  • VRDN N/A
  • CDLR N/A
  • EPS
  • VRDN N/A
  • CDLR 0.78
  • Revenue
  • VRDN $305,000.00
  • CDLR $546,159,718.00
  • Revenue This Year
  • VRDN N/A
  • CDLR $143.84
  • Revenue Next Year
  • VRDN $34,044.63
  • CDLR $66.36
  • P/E Ratio
  • VRDN N/A
  • CDLR $5.95
  • Revenue Growth
  • VRDN 5.90
  • CDLR 277.89
  • 52 Week Low
  • VRDN $9.90
  • CDLR $17.37
  • 52 Week High
  • VRDN $27.20
  • CDLR $27.33
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.01
  • CDLR 34.76
  • Support Level
  • VRDN $21.65
  • CDLR $18.65
  • Resistance Level
  • VRDN $24.23
  • CDLR $19.24
  • Average True Range (ATR)
  • VRDN 1.11
  • CDLR 0.46
  • MACD
  • VRDN -0.03
  • CDLR -0.08
  • Stochastic Oscillator
  • VRDN 68.07
  • CDLR 7.14

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Share on Social Networks: